Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quidel Will Seek To Carve Out Niche For QUS-2 In Crowded Market

This article was originally published in The Gray Sheet

Executive Summary

Quidel is looking to expand the ultrasound bone sonometer market by appealing to an untapped group of physicians interested in providing a point-of-care service with its low cost, portable QUS-2 system.

You may also be interested in...



Quidel LTF Format Pregnancy, Strep A Point-Of-Care Tests Expected By 2004

Quidel will expand its LTF layered thin film point-of-care test offerings to include pregnancy and Strep A by the end of 2003, the firm says

Quidel LTF Format Pregnancy, Strep A Point-Of-Care Tests Expected By 2004

Quidel will expand its LTF layered thin film point-of-care test offerings to include pregnancy and Strep A by the end of 2003, the firm says

Quidel Rounds Out Women's Health Offerings Via Metra Biosystems Buy

Quidel's cash acquisition of Metra Biosystems for $23 mil. will help the firm round out its women's health product portfolio.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013735

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel